Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine
Clinical trial NCT05285384 · COMPLETED
Trial details
- NCT number
- NCT05285384
- Sponsor
- Cinnagen
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-04
- Primary completion
- 2022-03-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.